Market Research Logo

Santen Pharmaceutical Co Ltd (4536) - Financial and Strategic SWOT Analysis Review

Santen Pharmaceutical Co Ltd (4536) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Santen Pharmaceutical Co Ltd (Santen) focuses on the development and manufacture and commercialization of pharmaceutical products and medical devices. The ocmpany specializes in ophthalmological products. Its product portfolio includes prescription ophthalmic products, OTC drugs, anti-allergy ophthalmic products, and medical devices such as intraocular lenses, among others. Santen markets its products under brand names such as Livostin, Alesion, Tarivid, Metadate, Cravit, Diquas and Hyalein, among others. It operates through group companies in Japan, the Netherlands, France, Switzerland, Finland,Germany, Spain, Sweden, the UK, Italy, Russia, China, Korea, Taiwan, India, Singapore, Thailand, Malaysia, Philippines, Hong Kong and China. It also has offices, laboratories and plants in Japan, China, Finland and Vietnam. Santen is headquartered in Kita-ku, Osaka, Japan.

Santen Pharmaceutical Co Ltd Key Recent Developments

May 10,2017: Santen Reports Fiscal 2016 Consolidated Performance
Apr 07,2017: Santen Announces Strategic Investment in Regenerative Patch Technologies
Mar 15,2017: Santen Pharmaceutical: Notice of Corporate Officer Appointments
Feb 07,2017: Santen Pharma Reports Revenue Of JPY150.7 Billion In Nine Months Ended December 31, 2016
Nov 02,2016: Santen Consolidated Results for Q2 Fiscal 2016

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company 5
Santen Pharmaceutical Co Ltd - Key Facts 5
Santen Pharmaceutical Co Ltd - Key Employees 6
Santen Pharmaceutical Co Ltd - Major Products and Services 8
Santen Pharmaceutical Co Ltd - History 9
Santen Pharmaceutical Co Ltd - Company Statement 10
Santen Pharmaceutical Co Ltd - Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 – Company Analysis 14
Santen Pharmaceutical Co Ltd - Business Description 14
Santen Pharmaceutical Co Ltd - Corporate Strategy 15
Santen Pharmaceutical Co Ltd - SWOT Analysis 16
SWOT Analysis - Overview 16
Santen Pharmaceutical Co Ltd - Strengths 16
Santen Pharmaceutical Co Ltd - Weaknesses 17
Santen Pharmaceutical Co Ltd - Opportunities 18
Santen Pharmaceutical Co Ltd - Threats 19
Santen Pharmaceutical Co Ltd - Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios - Capital Market Ratios 21
Financial Ratios - Annual Ratios 22
Performance Chart 25
Financial Performance 25
Financial Ratios - Interim Ratios 26
Financial Ratios - Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29
Santen Pharmaceutical Co Ltd, Recent Deals Summary 30
Section 5 – Company’s Recent Developments 31
May 10, 2017: Santen Reports Fiscal 2016 Consolidated Performance 31
Apr 07, 2017: Santen Announces Strategic Investment in Regenerative Patch Technologies 32
Mar 15, 2017: Santen Pharmaceutical: Notice of Corporate Officer Appointments 33
Feb 07, 2017: Santen Pharma Reports Revenue Of JPY150.7 Billion In Nine Months Ended December 31, 2016 35
Nov 02, 2016: Santen Consolidated Results for Q2 Fiscal 2016 36
Oct 03, 2016: Santen: Personnel Changes of Corporate Officer 37
May 11, 2016: Santen Reports Fiscal 2015 Consolidated Performance 38
Feb 02, 2016: Santen Pharma Reports Revenue Of JPY149.2 Billion In Nine Months Ended December 31, 2015 39
Section 6 – Appendix 40
Methodology 40
Ratio Definitions 40
About GlobalData 44
Contact Us 44
Disclaimer 44
List of Tables
Santen Pharmaceutical Co Ltd, Key Facts 5
Santen Pharmaceutical Co Ltd, Key Employees 6
Santen Pharmaceutical Co Ltd, Major Products and Services 8
Santen Pharmaceutical Co Ltd, History 9
Santen Pharmaceutical Co Ltd, Other Locations 11
Santen Pharmaceutical Co Ltd, Subsidiaries 12
Santen Pharmaceutical Co Ltd, Key Competitors 20
Santen Pharmaceutical Co Ltd, Ratios based on current share price 21
Santen Pharmaceutical Co Ltd, Annual Ratios 22
Santen Pharmaceutical Co Ltd, Annual Ratios (Cont...1) 23
Santen Pharmaceutical Co Ltd, Annual Ratios (Cont...2) 24
Santen Pharmaceutical Co Ltd, Interim Ratios 26
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 29
Santen Pharmaceutical Co Ltd, Recent Deals Summary 30
Currency Codes 40
Capital Market Ratios 40
Equity Ratios 41
Profitability Ratios 41
Cost Ratios 42
Liquidity Ratios 42
Leverage Ratios 43
Efficiency Ratios 43
List of Figures
Santen Pharmaceutical Co Ltd, Performance Chart (2013 - 2017) 25
Santen Pharmaceutical Co Ltd, Ratio Charts 27
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 28
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 29

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report